Skip to main content

Skin clinical trials at UC Cancer

1 research study open to eligible people

Showing trials for
  • Trial of Ixazomib for Kaposi Sarcoma

    open to eligible people ages 18 years and up

    This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

    at UCLA

Last updated: